Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

289 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.
Groen-van Schooten TS, Harrasser M, Seidel J, Bos EN, Fleitas T, van Mourik M, Pouw RE, Goedegebuure RSA, Doeve BH, Sanders J, Bos J, van Berge Henegouwen MI, Thijssen VLJL, van Grieken NCT, van Laarhoven HWM, de Gruijl TD, Derks S. Groen-van Schooten TS, et al. Among authors: de gruijl td. Front Immunol. 2024 Apr 4;15:1372272. doi: 10.3389/fimmu.2024.1372272. eCollection 2024. Front Immunol. 2024. PMID: 38638445 Free PMC article.
Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer.
Heeren AM, van Dijk I, Berry DRAI, Khelil M, Ferns D, Kole J, Musters RJP, Thijssen VL, Mom CH, Kenter GG, Bleeker MCG, de Gruijl TD, Jordanova ES. Heeren AM, et al. Among authors: de gruijl td. Front Immunol. 2018 Jul 11;9:1598. doi: 10.3389/fimmu.2018.01598. eCollection 2018. Front Immunol. 2018. PMID: 30050535 Free PMC article.
Human Bone Marrow-Derived Myeloid Dendritic Cells Show an Immature Transcriptional and Functional Profile Compared to Their Peripheral Blood Counterparts and Separate from Slan+ Non-Classical Monocytes.
van Leeuwen-Kerkhoff N, Lundberg K, Westers TM, Kordasti S, Bontkes HJ, Lindstedt M, de Gruijl TD, van de Loosdrecht AA. van Leeuwen-Kerkhoff N, et al. Among authors: de gruijl td. Front Immunol. 2018 Jul 16;9:1619. doi: 10.3389/fimmu.2018.01619. eCollection 2018. Front Immunol. 2018. PMID: 30061890 Free PMC article.
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma.
Huijts CM, Werter IM, Lougheed SM, Goedegebuure RS, van Herpen CM, Hamberg P, Tascilar M, Haanen JB, Verheul HM, de Gruijl TD, van der Vliet HJ; Dutch WIN-O Consortium. Huijts CM, et al. Among authors: de gruijl td. Cancer Immunol Immunother. 2019 Feb;68(2):319-329. doi: 10.1007/s00262-018-2248-3. Epub 2018 Nov 9. Cancer Immunol Immunother. 2019. PMID: 30413837 Free PMC article. Clinical Trial.
Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types.
van den Ende T, van den Boorn HG, Hoonhout NM, van Etten-Jamaludin FS, Meijer SL, Derks S, de Gruijl TD, Bijlsma MF, van Oijen MGH, van Laarhoven HWM. van den Ende T, et al. Among authors: de gruijl td. Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188386. doi: 10.1016/j.bbcan.2020.188386. Epub 2020 Jun 12. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32540465 Free article.
289 results